Colorectal cancer, a rising health concern of both east and west , can be prevented and it's mortality can be reduced by screening all men and women of average risk at the age of 50 years or older and at an earlier age for high risk group of colorectal cancer. Several tests are available for colon cancer screening, including fecal occult blood test (FOBT), flexible sigmoidoscopy, double-contrast barium enema, and colonoscopy. Direct and indirect evidence indicates that all the tests are effective, but they differ in their sensitivity, specificity, cost, and safety. The available evidence does not currently support choosing one test over another. In addition, other new colorectal cancer tests, such as virtual colonoscopy or stool-based molecular testing, have the potential to become important screening tests in the future. Key Words : Colorectal cancer screening, fecal occult blood test, flexible sigmoidoscopy, double-contrast barium enema, colonoscopy, virtual colonoscopy 1. Resident, Phase-B, Colorectal Surgery, Bangabandhu sheikh mujib medical university, Dhaka.
Introduction:
Screening is the process of looking for or checking for health problems in population before they cause symptoms in order to improve outcomes by early detection 1, 2, 3 Colorectal cancer (CRC) is one of the most common cancers in the world. It is the third most common cancer in United Kingdom as well as in the United States of America . Colorectal cancer has become an important problem in Asian countries also. Reports from the World Health Organization (WHO) data set and from individual countries or cities in Asia show that the incidence of CRC is rising rapidly. It accounts for an estimated 1.2 million new cancer cases and over 630 000 cancer deaths per year, almost 8% of all cancer deaths.
Most colorectal cancers develop from precancerous polyps. Polyps are growths that arise in the lining of the colon and are visible when the bowel is examined by endoscopy (colonoscopy or sigmoidoscopy). There are two main types of polyps: adenomatous and hyperplastic. Adenomatous polyps can become cancerous over time; this progression takes at least 10 years in most people From the time the first abnormal cells start to grow into precancerous polyps, it usually takes about 10 to 15 years for them to develop into colorectal cancer. Regular screening can, in many cases, prevent colorectal cancer altogether. This is because some precancerous polyps, or growths, can be found and removed before they have the chance to turn into cancer. Screening can also result in finding colorectal cancer early, when it is highly curable 1 . So screening can save lives by prevention and providing curative treatment of colorectal cancer 4-6 .
The National Polyp Study (USA) showed in its surveillance program that individuals who had their polyps removed experienced a 90% reduction in the incidence of colorectal cancer. The few patients in the study who did develop colorectal cancer had their cancer discovered at early, surgically or endoscopically curable stages 7 .
Adenoma-carcinoma sequence 8 .
Since most colon polyps and early cancers are silent (produce no symptoms), it is important to do screening and surveillance for colon cancer in patients without symptoms or signs of the polyps or cancers. Recommendations for cost-effective public screening and surveillance have been promulgated and endorsed by numerous societies including the American Cancer Society, the National Cancer Institute, American College of Gastroenterology, American Medical Association, American College of Physicians, etc 7 .
In Asia, screening with faecal occult blood test is a national policy only in Japan, Taiwan and Korea 6 . In Bangladesh, currently the awareness of the importance of CRC screening is very low especially among the general population as well as the policy makers which resulted in inadequate resources allocation for faecal occult blood test and colonoscopy as a consequence patients are presenting with CRC in advanced stage. • Sigmoidoscopy In this test, the rectum and lower colon are examined using a lighted instrument called a sigmoidoscope. During sigmoidoscopy, precancerous and cancerous growths in the rectum and lower colon can be found and either removed or biopsied. Studies suggest that regular screening with sigmoidoscopy after age 50 can help reduce the number of deaths from colorectal cancer 2,9 .
• Colonoscopy
In this test, the rectum and entire colon are examined using a lighted instrument called a colonoscope. During colonoscopy, precancerous and cancerous growths throughout the colon can be found and either removed or biopsied, including growths in the upper part of the colon, where they would be missed by sigmoidoscopy. A thorough cleansing of the colon is necessary before this test, and most patients receive some form of sedation 2
• Virtual colonoscopy (CT colonography)
In this test, special x-ray equipment is used to produce pictures of the colon and rectum. A computer then assembles these pictures into detailed images that can show polyps and other abnormalities. Because it is less invasive than standard colonoscopy and sedation is not needed, virtual colonoscopy may cause less discomfort and take less time to perform. As with standard colonoscopy, a thorough cleansing of the colon is necessary before this test.
Virtual endoluminal view is reconstructed by computer processing to simulate a conventional endoluminal view of the colon 10 .
• Double contrast barium enema (DCBE)
In this test, a series of x-rays of the entire colon and rectum are taken after the patient is given an enema with a barium solution and air is introduced into the colon. The barium and air help to outline the colon and rectum on the x-rays. These people are best referred to a center with experience in the surveillance and management of inflammatory bowel disease.
What happens if a colorectal cancer screening test shows an abnormality
If an abnormality is seen in FOBT, patient is advised for colonoscopy. If an abnormality is seen in colonoscopy biopsy is taken or if lesion is polyp then polypectomy is done. Further management depends on histopathology report.
New tests on the horizon.
Genetic testing of stool samples is being studied as a possible way to screen for colorectal cancer. The lining of the colon is constantly shedding cells into the stool. Testing stool samples for genetic alterations that occur in colorectal cancer cells may help doctors find evidence of cancer or precancerous growths. Research conducted thus far has shown that this kind of test can detect colorectal cancer in people already diagnosed with this disease by other means. However,
Pros and cons of these screening tests.
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Conclusion:
Colorectal cancer screening reduces death from colorectal cancer and can decrease the incidence of disease through removal of adenomatous polyps. Several available screening options seem to be effective, but the single best screening approach cannot be determined because data are insufficient.
In our context to reduce the load of CRC as well as the health budget people should be brought in the screening programme. Considering the socioeconomic condition we should adopt a secondary programme which costs minimally. Our recommendation is to spread awareness in the different forum regarding CRC and at least FOBT can be introduced as an interval step.
